A novel approach for modifying tumor cell-derived plasma membrane vesicles to contain encapsulated IL-2 and engrafted costimulatory molecules for use in tumor immunotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/11857387

Int. J. Cancer 2002 Mar 1 98 1 63-72

Download in:

View as

Triples

General Info

PMID
11857387